CD44 and neoplasm: To examine whether the inactivation of TCF21 in mutated cancer cells was responsible for CD44-induced 5-FU resistance, we elevated the expression of TCF21 in knockout and mutant p53 tumor HCT116–derived cell lines to verify the effects on chemoresistance.